Dai-ichi Life Insurance Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Sell
3,479
-5,949
-63% -$3.12M 0.05% 274
2025
Q1
$5.98M Sell
9,428
-494
-5% -$313K 0.17% 129
2024
Q4
$7.07M Sell
9,922
-2,470
-20% -$1.76M 0.2% 115
2024
Q3
$13M Sell
12,392
-2,383
-16% -$2.51M 0.33% 73
2024
Q2
$15.5M Buy
14,775
+111
+0.8% +$117K 0.38% 66
2024
Q1
$14.1M Sell
14,664
-3,433
-19% -$3.3M 0.32% 73
2023
Q4
$15.9M Buy
18,097
+750
+4% +$659K 0.33% 71
2023
Q3
$14.3M Buy
17,347
+79
+0.5% +$65K 0.31% 73
2023
Q2
$12.4M Sell
17,268
-14,794
-46% -$10.6M 0.26% 80
2023
Q1
$26.3M Buy
32,062
+1,008
+3% +$828K 0.58% 37
2022
Q4
$22.4M Buy
31,054
+672
+2% +$485K 0.52% 39
2022
Q3
$20.9M Buy
30,382
+1,000
+3% +$689K 0.52% 40
2022
Q2
$17.4M Sell
29,382
-13,018
-31% -$7.7M 0.39% 54
2022
Q1
$29.6M Sell
42,400
-1,978
-4% -$1.38M 0.47% 43
2021
Q4
$28M Hold
44,378
0.36% 57
2021
Q3
$26.9M Buy
44,378
+1,284
+3% +$777K 0.35% 53
2021
Q2
$24.1M Buy
43,094
+12,817
+42% +$7.16M 0.3% 61
2021
Q1
$14.3M Sell
30,277
-1,723
-5% -$815K 0.2% 89
2020
Q4
$15.5M Buy
32,000
+8,340
+35% +$4.03M 0.22% 79
2020
Q3
$13.2M Buy
23,660
+4,544
+24% +$2.54M 0.24% 80
2020
Q2
$11.9M Buy
19,116
+9,803
+105% +$6.11M 0.27% 69
2020
Q1
$4.55M Buy
9,313
+4,500
+93% +$2.2M 0.17% 135
2019
Q4
$1.81M Sell
4,813
-5,000
-51% -$1.88M 0.04% 340
2019
Q3
$2.72M Hold
9,813
0.07% 278
2019
Q2
$3.07M Hold
9,813
0.07% 256
2019
Q1
$4.03M Buy
9,813
+113
+1% +$46.4K 0.1% 213
2018
Q4
$3.62M Hold
9,700
0.1% 218
2018
Q3
$3.92M Sell
9,700
-29
-0.3% -$11.7K 0.08% 218
2018
Q2
$3.36M Sell
9,729
-1,416
-13% -$488K 0.08% 247
2018
Q1
$3.84M Hold
11,145
0.08% 224
2017
Q4
$4.19M Hold
11,145
0.08% 215
2017
Q3
$4.98M Sell
11,145
-6,000
-35% -$2.68M 0.11% 188
2017
Q2
$8.42M Buy
17,145
+1,001
+6% +$492K 0.19% 115
2017
Q1
$6.26M Buy
16,144
+8,000
+98% +$3.1M 0.17% 143
2016
Q4
$2.99M Buy
+8,144
New +$2.99M 0.09% 235